Median survival is the amount of time at which 50% of people with a condition 50% are still alive and 50% have died. There are two basic types of lung cancer: small cell (SCLC), the most aggressive ...

Survival depends on many factors, so no one can tell you exactly how long you’ll live. It depends on your individual condition, type of cancer, treatment and level of fitness. Survival for testicular ...

By selectively modulating proteins involved in these pathways, USPs contribute to either promoting or inhibiting cancer cell survival. The review explores the dual role of PCD in BC, where certain ...

Lung cancer is the leading cause of cancer deaths among both men and women. Small-cell lung cancer (SCLC ... diagnosed before you notice symptoms. Survival depends on early diagnosis.

Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ is the only DLBCL MRD ...

In a Phase IIb trial for stage IIIb/IV non-small-cell lung cancer (NSCLC), patients who received L-BLP25 had a median survival of 30.6 months versus 13.3 months for those who did not receive the ...

The global cell based assays market was projected to attain US$ 20.2 billion in 2023. It is anticipated to garner a 6.4% CAGR ...

A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...

Understanding the differences in the mutations that ... Mar. 13, 2025 — Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with ...

In localized non-small cell lung cancer (NSCLC), a tumor's ... at UT Southwestern—have developed an isotope infusion assay to study cancer metabolism in 90 patients while their tumors were ...